Mick Milsom

milsommick.bsky.social

04 October 2026 11:57

New publication from the groups of Duncan Odom, Marieke Essers and myself: Concentrating cell-type-specific transcriptional signatures in bone marrow from interspecies comparisons: Cell Genomics www.cell.com/cell-genomic... @dkfz.bsky.social

Kazuhiro Maeshima

kazu-maeshima.bsky.social

09 September 2026 11:30

Is euchromatin really “open”? 🧬 Using super-resolution imaging🔬 our new study @natgenet.nature.com reveals: Euchromatin forms condensed domains in live cells. Cohesin constrains them and prevents domain mixing for proper transcriptional insulation🚧 🔗 www.nature.com/articles/s41... (1/2)

Akis (Argyris) Papantonis

akispapantonis.bsky.social

22 July 2026 05:15

Our latest is now out in @nataging.nature.com giving reason to celebrate! Led by talented Spiros Palikyras, it improves our preprint (posted 2 years ago!) dissecting the mechanism and functional consequences of CTCF clustering upon senescence commitment of human cells. www.nature.com/articles/s43...

Jonas Koeppel

jonaskoeppel.bsky.social

05 June 2026 12:14

22/n On a personal note, I’ll soon start an independent research group in the Genome Biology Unit at EMBL Heidelberg. If you enjoy this type of work and want to engineer genomes at the largest scale, please reach out! jonas-koeppel.github.io/koeppellab/ www.embl.org/groups/koepp...

Daniel Lipka

dblipka.bsky.social

30 May 2026 05:22

🧵 NEW PAPER in @bloodjournal.bsky.social! Why do IDH1 mutations almost exclusively drive myeloid #leukemia, while IDH2 mutations occur in both myeloid AND lymphoid cancers? 🤔 #AML #Epigenetics Despite sharing the same biochemical mechanism, they are NOT equivalent. Here's what we found 👇